-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent Biologics Wins NMPA Approval for First Domestic CTLA-4 Antibody TABOSUN in Colon Cancer

Reuters·12/25/2025 08:45:31

Please log in to view news